$APHA get NICE mention in new report on the FDA CBD Trials http://fortunenewswire.com/aurora-cannabis-acb-and-others-receive-price-upgrades-following-cbd-trial-update-research-results/ Top Cannabis companies such as Aphria (NYSE:APHA), Cronos Group (NASDAQ:CRON), Canopy Growth (NYSE:CGC) and Aurora Cannabis (NYSE:ACB) are among the most anticipated cannabis stocks to monitor during these trials, which is set to take place in April to look into how the FDA might legalize CBD-additives in food products. These four cannabis giants stand to benefit significantly from a positive out-come of the trails, which ultimately aim to loosen the constraints of adding cannabis related products to food and drinks. Come on baby, lets break out!